Articles Tagged With: contraceptive
-
Contraception: More Effective Than Ever?
A new analysis from the National Survey of Family Growth demonstrates a decrease from 12% in 2002 to 10% in 2006-2010 in the overall rate of failure among women using reversible methods of contraception.
-
Reproductive Rights in 2017: Standing Strong for Women
The evidence strongly suggests that comprehensive family planning services provided under the Affordable Care Act that include subsidized coverage for highly effective long-acting reversible contraception have contributed to a decrease in the rate of unintended pregnancy and a sharp decline in abortions. As women’s healthcare providers, we should be leaders in standing up to policy changes that will endanger women and threaten our most vulnerable citizens.
-
When to Start Progestin-only Contraceptives After Medical Abortion
In this randomized, controlled trial, provision of depot medroxyprogesterone acetate on the same day as mifepristone for medical abortion decreased efficacy a small amount and had no effect on repeat pregnancy at six months. Whether this is clinically relevant will depend on individual patient counseling and the woman’s desire for convenient contraceptive coverage.
-
Federal Agencies Issue More Family Planning Rules
Federal agencies are continuing to issue regulations and guidance with a sense of urgency, and, in several cases, the implications for family planning care may be profound.
-
Research Eyes Hormonal Contraceptive Use And Impact on Vitamin D Levels
Women risk having their vitamin D levels fall when they stop using birth control pills or other contraceptives containing estrogen, new research indicates. This finding has clinical implications when counseling women who are planning to conceive and identifying women who may be at risk of deficiency.
-
Deaths From Ovarian Cancer Fall Worldwide Due to Oral Contraceptive Use, Data Show
Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline through 2020 in the United States, European Union, and, to a lesser extent, in Japan, according to newly published research. The primary reason is the use of oral contraceptives and the long-term protection against ovarian cancer that they provide, say researchers.
-
FDA Approves IUS Contraceptive For Up to Five Years
The FDA approved Kyleena, a levonorgestrel-releasing, progestin-containing IUS, for up to five years.
-
PCOS and Hormonal Contraception: A Tale of Two Syndromes?
Emerging evidence supports that two metabolic phenotypes exist among women with PCOS. For metabolically healthy PCOS patients, managing menstrual symptoms, anovulation and androgen excess with COCs provides a simple and well-tolerated treatment regimen. In contrast, PCOS patients with metabolic syndrome are at high risk for type 2 diabetes, and COC use may contribute to hyperinsulinemia, adverse lipid changes, and endothelial changes associated with adverse cardiovascular risk. The use of a levonorgestrel intrauterine device combined with spironolactone (to manage hyperandrogenism) and metformin (to manage hyperinsulinism) may offer advantages to metabolically unhealthy PCOS patients.
-
Identify Contraceptive Considerations For Female Patients Who Have Diabetes
What should clinicians keep in mind when providing family planning for women with diabetes? Not only are these women at increased risk of macrovascular complications, microvascular complications, and metabolic syndrome, but the reproductive health implications they face include effects on fertility, vaginitis, urinary tract infections, maternal risks, and neonatal risks, says Eleanor Bimla Schwarz, MD, MS, professor of medicine at the University of California, Davis.
-
The Affordable Care Act & Birth Control Coverage — What Every Family Planning Worker Should Know
What do you know about the Affordable Care Act and its birth control coverage requirement?